138 related articles for article (PubMed ID: 25986475)
1. Serum C-reactive protein and overall survival of patients with osteosarcoma.
Li X; Tian F; Wang F; Li Y
Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
[TBL] [Abstract][Full Text] [Related]
2. Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients.
Xu L; Zhao Q; Huang S; Li S; Wang J; Li Q
Tumour Biol; 2015 Feb; 36(2):669-73. PubMed ID: 25286759
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma.
Funovics PT; Edelhauser G; Funovics MA; Laux C; Berzaczy D; Kubista B; Kotz RI; Dominkus M
Int Orthop; 2011 Oct; 35(10):1529-36. PubMed ID: 21249357
[TBL] [Abstract][Full Text] [Related]
4. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma.
Yu H; Yu J; Ren Y; Yang Y; Xiao X
PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014
[TBL] [Abstract][Full Text] [Related]
5. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
[TBL] [Abstract][Full Text] [Related]
6. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
7. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
9. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
12. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients.
Jettoo P; Tan G; Gerrand CH; Rankin KS
J Orthop Surg (Hong Kong); 2019; 27(2):2309499019838293. PubMed ID: 30909848
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
14. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P
BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.
Yi JH; Wang D; Li ZY; Hu J; Niu XF; Liu XL
PLoS One; 2014; 9(5):e94632. PubMed ID: 24800842
[TBL] [Abstract][Full Text] [Related]
19. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
[TBL] [Abstract][Full Text] [Related]
20. Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer.
Schmid M; Schneitter A; Hinterberger S; Seeber J; Reinthaller A; Hefler L
Obstet Gynecol; 2007 Dec; 110(6):1231-6. PubMed ID: 18055714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
